⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2162515 | 0.71 | — | — | |
| SCHEMBL2162520 | 0.71 | — | — | |
| SCHEMBL4957488 | 0.69 | — | — | |
| SCHEMBL834040 | 0.65 | — | — | |
| SCHEMBL343501 | 0.62 | — | — | |
| SCHEMBL11461024 | 0.60 | — | — | |
| SCHEMBL12475284 | 0.60 | — | — | |
| SCHEMBL1047155 | 0.58 | — | — | |
| SCHEMBL261532 | 0.58 | — | — | |
| SCHEMBL261531 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160311778-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2016-10-27 | — | — | US | disclosed |